Evidence map›Paper›PMID 10595828›Full record

ArticleJournal of endocrinological investigation1999

Independent expression of serological markers of thyroid autoimmunity and hepatitis virus C infection in the general population: results of a community-based study in north-western Sardinia.

A Loviselli, A Oppo, F Velluzzi, F Atzeni, G L Mastinu, P Farci, G Orgiana, A Balestrieri, P L Cocco, S Mariotti

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of endocrinological investigation, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Bipolar disorder and antithyroid antibodies: review and case series.International journal of bipolar disorders · 2016
    Article
  8. Article
  9. Autoimmune manifestations in viral hepatitis.Seminars in immunopathology · 2013
    Review
  10. Review
  11. Interferon induced thyroiditis.Best practice & research. Clinical endocrinology & metabolism · 2009
    Review
  12. Risk of malignant lymphoma following viral hepatitis infection.International journal of hematology · 2008
    Article
  13. Interferon alpha treatment and thyroid dysfunction.Endocrinology and metabolism clinics of North America · 2007
    Review
  14. Fifteen-year follow-up of thyroid function in lithium patients.Journal of endocrinological investigation · 2007
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

A LoviselliCattedra di Endocrinologia, Dipartimento di Scienze Mediche M. Aresu, Università di Cagliari, Italy.
A Oppo
F Velluzzi
F Atzeni
G L Mastinu
P Farci
G Orgiana
A Balestrieri
P L Cocco
S Mariotti
University of Cagliari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To assess the relationship between serological markers of thyroid autoimmunity and chronic hepatitis C, we surveyed the general population of two villages in the region of Sardinia, Italy, where infection with hepatitis viruses is endemic and the prevalence of autoimmune diseases is elevated. A total of 1310 subjects aged 6-88 years (65% of the total resident population) participated in the survey, and 1233 (94%; 444 males and 789 females) agreed to provide a blood sample. Autoantibodies to thyroid peroxidase (anti-TPO) were measured by radioimmunoassay; antibodies to HCV (anti-HCV) by a third generation enzyme immunoassay and borderline positive results confirmed by recombinant immunoblot assay. For both anti-HCV and anti-TPO the age- and gender-standardized prevalence rates (SPR) were calculated and the significance of the association between the two antibodies tested by Yates corrected chi2 test. The overall SPR for anti-HCV was 50.7x10(-3) (86/1,233), similar between men [49.1x10(-3) (22/444)] and women [52.3x10(-3) (64/789)]. The overall SPR for anti-TPO was 136.9x10(-3) (204/1,233), and that among women [201x10(-3) (174/789)] was almost 3-fold that among men [71.6x10(-3) (30/444)]. A concurrent anti-HCV and anti-TPO positivity was found in a small minority of subjects [8/1,233 (0.65%)], all women aged 57-81 years. The SPR for the two concurrent events was 3.3x10(-3), which was not significantly different (Yates corrected chi2 test = 0.65) from that expected under the assumption of unrelated events. To explore whether HCV infection is a risk factor for anti-TPO positivity, we designed a case-control study with anti-TPO positive subjects as the cases, and anti-TPO negative subjects as the controls. The age- and gender-adjusted odd ratio (OR) was 0.4 (95% CI 0.2,0.7), indicating a negative association. In conclusion, no evidence for epidemiological association of circulating thyroid autoantibodies and antibodies to HCV was found. Our findings do not therefore support a pathogenetic link between HCV infection and thyroid autoimmunity.

Indexed as

AgedAged, 80 and overAge FactorsAutoimmune DiseasesFemaleHepacivirusHepatitis CHepatitis C AntibodiesHumansImmunoenzyme TechniquesIodide PeroxidaseItalyMaleMiddle AgedRisk FactorsSex CharacteristicsHepatitis C AntibodiesIodide Peroxidase

Identifiers

PMID10595828
OpenAlexW2062738860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.